genXone S.A. (WSE:GX1)

Poland · Delayed Price · Currency is PLN

5.76

+0.46 (8.68%)

Last updated: Oct 14, 2026, 3:50 PM CET

Market Cap	19.04M +1.1%
Revenue (ttm)	2.48M +24.2%
Net Income	-2.18M
EPS	-0.66
Shares Out	3.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,319
Open	5.18
Previous Close	5.30
Day's Range	5.04 - 5.82
52-Week Range	3.81 - 6.96
Beta	-0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About genXone

genXone S.A., a biotechnology company, provides nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally. The company offers whole genome, metagenome, shotgun metagenomic, plasmid DNA, and transcriptome sequencing services, as well as bioinformatic analysis. It also provides nucleic acid isolation; molecular diagnostics laboratory; and operates in the field of molecular genetics and bioinformatics. In addition, the company develops solutions in the form of laboratory protocols, as well as bioinforma... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2018

Employees 17

Stock Exchange Warsaw Stock Exchange

Ticker Symbol GX1

Full Company Profile

Financial Performance

In 2025, genXone's revenue was 2.34 million, an increase of 31.07% compared to the previous year's 1.79 million. Losses were -2.64 million, -32.78% less than in 2024.

Financial Statements